Development of a Single-Replicon miniBYV Vector for Co-expression of Heterologous Proteins

Hybrid Viral Vectors for Vaccine and Antibody Production in Plants

(2013) Vidadi Yusibov et al.   CURRENT PHARMACEUTICAL DESIGN

N-Glycosylation of Plant-produced Recombinant Proteins

(2013) Dirk Bosch et al.   CURRENT PHARMACEUTICAL DESIGN

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

(2013) Peter Pushko et al.   INTERVIROLOGY

In Plant Activation: An Inducible, Hyperexpression Platform for Recombinant Protein Production in Plants

(2013) B. Dugdale et al.   PLANT CELL

The closterovirus-derived gene expression and RNA interference vectors as tools for research and plant biotechnology

(2013) Valerian V. Dolja et al.   Frontiers in Microbiology

In vivo deglycosylation of recombinant proteins in plants by co-expression with bacterial PNGase F

(2013) Tarlan Mamedov et al.   Bioengineered

Virus-Derived Gene Expression and RNA Interference Vector for Grapevine

(2012) E. G. Kurth et al.   JOURNAL OF VIROLOGY

Utility of the P19 suppressor of gene-silencing protein for production of therapeutic antibodies inNicotianaexpression hosts

(2012) Freydoun Garabagi et al.   PLANT BIOTECHNOLOGY JOURNAL

Production of non-glycosylated recombinant proteins inNicotiana benthamianaplants by co-expressing bacterial PNGase F

(2012) Tarlan Mamedov et al.   PLANT BIOTECHNOLOGY JOURNAL

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

(2012) Natasha Kushnir et al.   VACCINE

Co-expression of multiple target proteins in plants from a tobacco mosaic virus vector using a combination of homologous and heterologous subgenomic promoters

(2011) Gourgopal Roy et al.   ARCHIVES OF VIROLOGY

Insect cells as factories for biomanufacturing

(2011) Jean-Christophe Drugmand et al.   BIOTECHNOLOGY ADVANCES

Mammalian cell protein expression for biopharmaceutical production

(2011) Jianwei Zhu   BIOTECHNOLOGY ADVANCES

Insect cell technology is a versatile and robust vaccine manufacturing platform

(2011) Jimmy A Mena et al.   Expert Review of Vaccines

A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates fromB. anthracisspore challenge

(2011) Vadim Mett et al.   Human vaccines & immunotherapeutics

Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants

(2011) Qiang Chen et al.   Human vaccines & immunotherapeutics

Plant-Produced Trastuzumab Inhibits the Growth of HER2 Positive Cancer Cells

(2010) Brittany M. Grohs et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Plant-specific glycosylation patterns in the context of therapeutic protein production

(2010) Véronique Gomord et al.   PLANT BIOTECHNOLOGY JOURNAL

A novel two-component Tobacco mosaic virus-based vector system for high-level expression of multiple therapeutic proteins including a human monoclonal antibody in plants

(2010) Gourgopal Roy et al.   VIROLOGY

N-glycosylation Engineering of Biopharmaceutical Expression Systems

(2009) P. Jacobs et al.   CURRENT MOLECULAR MEDICINE

Extremely High-Level and Rapid Transient Protein Production in Plants without the Use of Viral Replication

(2008) F. Sainsbury et al.   PLANT PHYSIOLOGY